• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单一简单问题在重症肌无力患者评估中的效用。

The utility of a single simple question in the evaluation of patients with myasthenia gravis.

机构信息

Ellen and Martin Prosserman Centre for Neuromuscular Diseases, Division of Neurology, Department of Medicine, University Health Network, University of Toronto, General Hospital, Room 5 EB 309, 200 Elizabeth Street, Toronto, Ontario, M5G 2C4, Canada.

出版信息

Muscle Nerve. 2018 Feb;57(2):240-244. doi: 10.1002/mus.25720. Epub 2017 Jun 27.

DOI:10.1002/mus.25720
PMID:28590545
Abstract

INTRODUCTION

Assessing myasthenia gravis (MG) can be challenging, and multiple scales are available to evaluate disease severity. We evaluated the utility of a single, simple question, as part of the MG evaluation: "What percentage of normal do you feel regarding your MG, 0%-100% normal?"

METHODS

A retrospective chart review of patients attending the neuromuscular clinic from January 2014 to December 2015 was performed. Responses were correlated with symptoms and signs, the Quantitative Myasthenia Gravis Score (QMGS), the Myasthenia Gravis Impairment Index (MGII), and the 15-item Myasthenia Gravis Quality of Life scale (MG-QOL15).

RESULTS

The total cohort included 169 patients. The percentage of normal correlated strongly with limb muscle weakness and MG scales, moderately with bulbar and respiratory symptoms, and weakly with ocular manifestations.

DISCUSSION

The question, "What percentage of normal do you feel regarding your MG?" is feasible and valid, and can be incorporated easily into routine clinical evaluation. Muscle Nerve 57: 240-244, 2018.

摘要

简介

评估重症肌无力 (MG) 具有一定挑战性,目前有多种量表可用于评估疾病严重程度。我们评估了一个简单问题在 MG 评估中的效用:“你感觉自己的 MG 正常程度为多少,正常的 0%-100%?”

方法

对 2014 年 1 月至 2015 年 12 月在神经肌肉科就诊的患者进行回顾性图表审查。将答复与症状和体征、定量重症肌无力评分 (QMGS)、重症肌无力损伤指数 (MGII) 和 15 项重症肌无力生活质量量表 (MG-QOL15) 进行相关性分析。

结果

总队列包括 169 名患者。正常百分比与肢体肌无力和 MG 量表高度相关,与延髓和呼吸症状中度相关,与眼肌表现弱相关。

讨论

“你感觉自己的 MG 正常程度为多少,正常的 0%-100%?”这个问题是可行且有效的,可轻松纳入常规临床评估中。《肌肉神经》57: 240-244, 2018。

相似文献

1
The utility of a single simple question in the evaluation of patients with myasthenia gravis.单一简单问题在重症肌无力患者评估中的效用。
Muscle Nerve. 2018 Feb;57(2):240-244. doi: 10.1002/mus.25720. Epub 2017 Jun 27.
2
The modified rankin scale to assess disability in myasthenia gravis: Comparing with other tools.用于评估重症肌无力残疾程度的改良Rankin量表:与其他工具的比较。
Muscle Nerve. 2014 Oct;50(4):501-7. doi: 10.1002/mus.24214.
3
Validation of the italian version of the 15-item Myasthenia Gravis Quality-of-Life questionnaire.15项重症肌无力生活质量问卷意大利语版本的验证
Muscle Nerve. 2017 Oct;56(4):716-720. doi: 10.1002/mus.25545. Epub 2017 Apr 27.
4
Electrophysiological testing is correlated with myasthenia gravis severity.电生理检查与重症肌无力的严重程度相关。
Muscle Nerve. 2017 Sep;56(3):445-448. doi: 10.1002/mus.25539. Epub 2017 Mar 23.
5
Validation of the 15-item myasthenia gravis quality of life questionnaire (MG-QOL15) Persian version.15项重症肌无力生活质量问卷(MG-QOL15)波斯语版本的验证
Muscle Nerve. 2016 Jun;54(1):65-70. doi: 10.1002/mus.25002. Epub 2016 Feb 26.
6
The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers.重症肌无力定量评分:与临床、电生理及实验室指标的比较
J Clin Neuromuscul Dis. 2012 Jun;13(4):201-5. doi: 10.1097/CND.0b013e31824619d5.
7
Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII).验证重症肌无力障碍指数(MGII)的意大利版本。
Neurol Sci. 2022 Mar;43(3):2059-2064. doi: 10.1007/s10072-021-05585-5. Epub 2021 Sep 9.
8
International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.对MG-QOL15进行国际临床计量学评估,结果对MG-QOL15进行了轻微修订并随后对MG-QOL15r进行了验证。
Muscle Nerve. 2016 Dec;54(6):1015-1022. doi: 10.1002/mus.25198. Epub 2016 Nov 7.
9
Patient-acceptable symptom states in myasthenia gravis.重症肌无力患者可接受的症状状态。
Neurology. 2020 Sep 22;95(12):e1617-e1628. doi: 10.1212/WNL.0000000000010574. Epub 2020 Aug 5.
10
Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite.重症肌无力高效评估工具的构建:重症肌无力综合评估量表
Muscle Nerve. 2008 Dec;38(6):1553-62. doi: 10.1002/mus.21185.

引用本文的文献

1
App- and Wearable-Based Remote Monitoring for Patients With Myasthenia Gravis and Its Specialists: Feasibility and Usability Study.基于应用程序和可穿戴设备对重症肌无力患者及其专科医生的远程监测:可行性和可用性研究。
JMIR Form Res. 2025 Mar 3;9:e58266. doi: 10.2196/58266.
2
Longitudinal relationships between free-living activities, fatigue, and symptom severity in myasthenia gravis using cohort and individualized models.运用队列研究和个体化模型探讨重症肌无力患者日常活动、疲劳与症状严重程度之间的纵向关系。
Muscle Nerve. 2025 Jan;71(1):33-42. doi: 10.1002/mus.28282. Epub 2024 Oct 30.
3
Using jitter analysis with concentric needle electrodes to assess disease status and treatment responses in myasthenia gravis.
使用同心针电极进行抖动分析以评估重症肌无力的疾病状态和治疗反应。
Clin Neurophysiol Pract. 2024 Jul 14;9:227-232. doi: 10.1016/j.cnp.2024.06.004. eCollection 2024.
4
Reply to letter in response to Rethinking the diagnosis of double-seronegative myasthenia gravis.对关于“重新思考双重血清阴性重症肌无力的诊断”的信件的回复
Eur J Neurol. 2024 Mar;31(3):e16152. doi: 10.1111/ene.16152. Epub 2023 Nov 22.
5
Clinical characteristics and treatment outcomes in patients with double-seronegative myasthenia gravis.双阴性重症肌无力患者的临床特征和治疗结局。
Eur J Neurol. 2024 Jan;31(1):e16022. doi: 10.1111/ene.16022. Epub 2023 Aug 16.
6
Time to achieve a patient acceptable symptom state in myasthenia gravis.重症肌无力患者达到可接受症状状态的时间。
Front Neurol. 2023 Jun 16;14:1187189. doi: 10.3389/fneur.2023.1187189. eCollection 2023.
7
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials.解决重症肌无力临床试验中的结局测量变异性问题。
Neurology. 2023 Sep 5;101(10):442-451. doi: 10.1212/WNL.0000000000207278. Epub 2023 Apr 19.
8
Current management of myasthenia gravis in Belgium: a single-center experience.当前比利时重症肌无力的治疗管理:单中心经验。
Acta Neurol Belg. 2023 Apr;123(2):375-384. doi: 10.1007/s13760-023-02187-0. Epub 2023 Jan 20.
9
Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study.皮下免疫球蛋白治疗重症肌无力的有效性:一项回顾性队列研究。
J Neurol. 2022 Dec;269(12):6572-6581. doi: 10.1007/s00415-022-11345-y. Epub 2022 Aug 22.
10
Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study.基于调查的研究:重症肌无力患者接种灭活 SARS-CoV-2 疫苗的安全性。
Front Immunol. 2022 Aug 5;13:923017. doi: 10.3389/fimmu.2022.923017. eCollection 2022.